A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis

Modern Rheumatology ◽

10.1080/14397595.2016.1176635 ◽

2016 ◽

Vol 27 (1) ◽

pp. 142-149 ◽

Author(s):

Shigeto Kobayashi ◽

Toru Yoshinari

Keyword(s):

Ankylosing Spondylitis ◽

Japanese Patients ◽

Long Term Study

Download Full-text

An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain

Journal of Pain Research ◽

10.2147/jpr.s63028 ◽

2014 ◽

pp. 439 ◽

Author(s):

Kenji Onouchi ◽

Kazumasa Yokoyama ◽

Tamotsu Yoshiyama ◽

Hiroaki Koga

Keyword(s):

Neuropathic Pain ◽

Japanese Patients ◽

Central Neuropathic Pain ◽

Long Term Study

Download Full-text

Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs

Modern Rheumatology ◽

10.3109/14397595.2014.899179 ◽

2014 ◽

Vol 24 (5) ◽

pp. 744-753 ◽

Author(s):

Tsutomu Takeuchi ◽

Tsukasa Matsubara ◽

Yukitomo Urata ◽

Eiichi Suematsu ◽

Shuji Ohta ◽

...

Keyword(s):

Japanese Patients ◽

Phase Iii ◽

Inadequate Response ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Long Term Study ◽

Disease Modifying

Download Full-text

Clinical efficacy and safety of brodalumab (KHK4827), antiinterleukin-17-receptor a monoclonal antibody, in Japanese patients with pustular psoriasis (generalized) and psoriatic erythroderma: A phase 3, open-label, long-term study (4827-004 study)

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2015.02.923 ◽

2015 ◽

Vol 72 (5) ◽

pp. AB228

Keyword(s):

Monoclonal Antibody ◽

Clinical Efficacy ◽

Japanese Patients ◽

Pustular Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Long Term Study

Download Full-text

Safety and tolerability of brexpiprazole in adults with schizophrenia: results of an open-label, long-term study

10.26226/morressier.5971be85d462b80290b524fb ◽

2017 ◽

Author(s):

Catherine Weiss

Keyword(s):

Long Term Study

Download Full-text

Effect of brexpiprazole on long-term remission in adults with schizophrenia: results of an open-label, long-term study

10.26226/morressier.5971be85d462b80290b52514 ◽

2017 ◽

Author(s):

Ross Baker

Keyword(s):

Long Term Study

Download Full-text

Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.014 ◽

2021 ◽

Author(s):

Hidemi Nakagawa ◽

Osamu Nemoto ◽

Atsuyuki Igarashi ◽

Hidehisa Saeki ◽

Kenji Kabashima ◽

...

Keyword(s):

Atopic Dermatitis ◽

Pediatric Patients ◽

Controlled Study ◽

Phase 3 ◽

Double Blind ◽

Long Term Study

Download Full-text

An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.12607 ◽

2017 ◽

Vol 72 (2) ◽

pp. 84-94 ◽

Author(s):

Hironobu Ichikawa ◽

Michio Hiratani ◽

Akihiro Yasuhara ◽

Noa Tsujii ◽

Takashi Oshimo ◽

...

Keyword(s):

Children And Adolescents ◽

Autistic Disorder ◽

Safety And Efficacy ◽

Long Term Study ◽

Open Label Extension

Download Full-text

Risperidone in levodopa-induced psychosis in advanced parkinson's disease: An open-label, long-term study

Movement Disorders ◽

10.1002/mds.870120423 ◽

1997 ◽

Vol 12 (4) ◽

pp. 610-612 ◽

Author(s):

Giuseppe Meco ◽

Andrea Alessandri ◽

Patrizia Giustini ◽

Vincenzo Bonifati

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Advanced Parkinson’S Disease ◽

Long Term Study

Download Full-text

Safety and efficacy of ipragliflozin in elderly versus non-elderly Japanese patients with type 2 diabetes mellitus: a subgroup analysis of the STELLA-LONG TERM study

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2018.1434145 ◽

2018 ◽

Vol 19 (4) ◽

pp. 327-336 ◽

Author(s):

Hiroshi Maegawa ◽

Kazuyuki Tobe ◽

Hiromi Tabuchi ◽

Ichiro Nakamura ◽

Satoshi Uno

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Safety And Efficacy ◽

Long Term Study ◽

Elderly Japanese ◽

Elderly Japanese Patients

Download Full-text

22 24-months on treatment: Open-label phase I/II long-term study of enzyme replacement therapy (ERT) with Gene-Activated® human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2007.08.027 ◽

2007 ◽

Vol 92 (4) ◽

pp. 16

Author(s):

Ari Zimran ◽

G. Altarescu ◽

C. Fratazzi ◽

R. Mensah ◽

D. Elstein

Keyword(s):

Enzyme Replacement Therapy ◽

Phase I ◽

Gaucher Disease ◽

Type I ◽

Enzyme Replacement ◽

Long Term Study ◽

Open Label Phase

Download Full-text